Overview
Floseal Treatment for Posterior Epistaxis Study
Status:
Completed
Completed
Trial end date:
2011-11-01
2011-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Effectiveness of Floseal for the treatment of posterior epistaxis.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ottawa Hospital Research Institute
Criteria
Inclusion Criteria:- age greater than 18 years of age
- posterior epistaxis
Exclusion Criteria:
- patients with anterior epistaxis
- known sensitivity to any of the materials of Floseal or the topical medications
administered as part of the evaluation and treatment of epistaxis (lidocaine,
xylometazoline hydrochloride)
- pregnant or breast feeding woman